Search - tctmd.com

Displaying 61 - 80 of 94

Sort: Relevancy | Date

News Daily News

HF Care Didn’t Suffer as Clinicians Turned to Telehealth in COVID-19

Caitlin E. Cox

October 13, 2021

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

News Conference News ESC 2021

In HFrEF, AI Shows Promise For Predicting Beta Blocker Response

Yael L. Maxwell

September 03, 2021

News Conference News ESC 2021

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

Shelley Wood

August 31, 2021

News Daily News

Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists

Todd Neale

July 09, 2021

News Industry News

Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes

June 29, 2021

News Daily News

A New Biomarker to Diagnose Acute Myocarditis?

Todd Neale

June 03, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Opinion CV Team Dispatch

May 2021 News Roundup

L.A. McKeown

May 01, 2021

News Conference News EHRA 2021

His-Bundle Pacing Gains Support in Pilot Study

Todd Neale

April 28, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

News Conference News AHA 2020

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

L.A. McKeown

November 18, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Features

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

Yael L. Maxwell

March 24, 2020

News Industry News

Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure

July 23, 2019

News Industry News

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

July 22, 2019

News Industry News

New study finds both components of blood pressure predict heart attack, stroke risk

July 17, 2019

News Industry News

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

July 15, 2019

News Daily News

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Michael O'Riordan

May 06, 2019

News Industry News

Ortho's VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries

April 16, 2019

Advertisement

HF Care Didn’t Suffer as Clinicians Turned to Telehealth in COVID-19

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

In HFrEF, AI Shows Promise For Predicting Beta Blocker Response

2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care

Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists

Medtronic Launches App-Based Study to Better Understand Relationship Between Atrial Fibrillation Disease Burden and Impact on Patient Outcomes

A New Biomarker to Diagnose Acute Myocarditis?

June 2021 News Roundup

May 2021 News Roundup

His-Bundle Pacing Gains Support in Pilot Study

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 Pandemic

Ortho Receives CE Mark for Enhanced VITROS® Immunodiagnostic Products NT-proBNP II Assay, an Aid in Diagnosing and Assessing Heart Failure

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

New study finds both components of blood pressure predict heart attack, stroke risk

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Ortho's VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content